Sort
51,593 grants matching “hepatitis”
Alcohol Pharmacotherapies Among Released Prisoners
$761,595Sandra Ann Springer · Yale University · R01 · FY2010 · AA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$761,504Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Refanalin for Liver Transplantation
$761,431Angion Biomedica Corporation · R44 · FY2004 · AA
Enhancing immune regulation in gene therapy for hemophilia
$761,303Roland W. Herzog · Indiana University Indianapolis · R01 · FY2021 · HL
Community-based, client-centered prevention homes to address the rural opioid epidemic
$761,008Ryan Patrick Westergaard · University Of Wisconsin-Madison · UH3 · FY2020 · DA
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer
$760,961Lopa Mishra · Feinstein Institute For Medical Research · U01 · FY2022 · CA
Innate Immune Control of West Nile Virus
$760,880Michael J Gale · University Of Washington · R01 · FY2016 · AI
Innate Immune Control of West Nile Virus
$760,880Michael J Gale · University Of Washington · R01 · FY2017 · AI
Innate Immune Control of West Nile Virus
$760,880Michael J Gale · University Of Washington · R01 · FY2015 · AI
RETROVIRUS EPIDEMIOLOGY DONOR STUDY (REDS) BLOOD CENTER
$760,862University Of California San Francisco · N01 · FY2000 · HB
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
$760,628Michael Agus · Boston Children'S Hospital · R01 · FY2007 · HL
Systems Biology Analysis of the Response to 2 HBV vaccines: Heplisav and Engerix
$760,628Robert L Coffman · Baylor Research Institute · U19 · FY2013 · AI
Computation and Repurposing to identfy antivirals directed against dominant
$760,572Vijay S Pande · Stanford University · U19 · FY2017 · AI
Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy
$760,561Grace A McComsey · Case Western Reserve University · R01 · FY2022 · DK
Deep Phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 Human Knockouts and Population Based Studies
$760,417Danish Saleheen · University Of Pennsylvania · R01 · FY2019 · HL
Alcohol Pharmacotherapies Among Released Prisoners
$760,400Sandra Ann Springer · Yale University · R01 · FY2011 · AA
Mechanisms for regulation of a novel class of anti-diabetic lipids
$760,278Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2022 · DK
Alcohol Pharmacotherapies Among Released Prisoners
$760,029Sandra Ann Springer · Yale University · R01 · FY2009 · AA
Infant Immunoprophylaxis against a Primate Lentivirus
$759,922Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · R37 · FY2012 · AI
HEPATITIS C: STUDIES OF IMMUNITY AND PATHOGENESIS
$759,817Rockefeller University · U19 · FY2003 · AI
FUNCTIONAL GENOMICS & VIROLOGY CORE
$759,770Michael G Katze · University Of Washington · P30 · FY2009 · DA
A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
$759,760Carl A Latkin · Johns Hopkins University · R01 · FY2021 · DA
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions
$759,667Harel Dahari · Loyola University Chicago · R01 · FY2022 · AI
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
$759,575Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2016 · CA
The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV Elimination
$759,561Risha Irvin · Johns Hopkins University · R01 · FY2023 · DA